Supplementary Tables S1 to S6 from Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA

Table S1: Genes and regions interrogated by the targeted mutation panel, assuming 75bp amplicon size. Table S2: Mutations detected with targeted driver gene panel in Early and Very Early plasma samples. Table S3: Clinical characteristics of patients in whom Early Plasma sample scored positive. Table S4: Summary of ctDNA results in Early and Very Early plasma samples. Table S5: Cancer types and staging information for patients who tested positive and negative in their Early plasma samples. Table S6: Bona fide Mutations.)